Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Aneurysm
Description
Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics. MeSH
Hierarchy View
Subtype Terms (12)
Aneurysm, Ruptured
2 approved drugs
Aortic Aneurysm
11 drugs (8 approved, 3 experimental)
Coronary Aneurysm
8 approved drugs
Intracranial Aneurysm
36 drugs (32 approved, 4 experimental)
Phase 3 Indicated Drugs (5)
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (10)
Organization Involved with Phase 4 Indications (41)
Organization Involved with Phase 3 Indications (27)
Organization Involved with Phase 2 Indications (50)
Icahn School of Medicine at Mount Sinai
Moorgreen Hospital, Southampton
National Institute for Health Research, United Kingdom
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (28)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
